Betamethasone Dipropionate USP, 0.05% .5 mg/g
Betamethasone Dipropionate USP, 0.05% · OINTMENT · TruPharma LLC
Betamethasone Dipropionate USP, 0.05% is a ointment containing betamethasone dipropionate usp, 0.05% at .5 mg/g, taken topical. Manufactured by TruPharma LLC.
Key Facts
- Brand Name
- Betamethasone Dipropionate USP, 0.05%
- Generic Name
- Betamethasone Dipropionate USP, 0.05%
- NDC Code (Product)
52817-824- Manufacturer
- TruPharma LLC
- Strength
- .5 mg/g
- Dosage Form
- OINTMENT
- Route
- TOPICAL
- Marketing Status
- Application #
- ANDA215186
- Marketing Start
- 02/18/2022
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage & Administration
DOSAGE AND ADMINISTRATION Apply a thin film of betamethasone dipropionate ointment to the affected skin areas once daily. In some cases, twice daily dosage may be necessary. If an infection develops, appropriate antimicrobial therapy should be instituted. Betamethasone dipropionate ointment should not be used with occlusive dressings.
Contraindications
CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse Reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently when betamethasone dipropionate ointment is used as recommended in the DOSAGE AND ADMINISTRATION section. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria. Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia and glucosuria in some patients.
Frequently Asked Questions
What is Betamethasone Dipropionate USP, 0.05% used for?
Betamethasone Dipropionate USP, 0.05% contains Betamethasone Dipropionate USP, 0.05%. It is a ointment taken topical. Consult your doctor for specific uses.
Is Betamethasone Dipropionate USP, 0.05% a controlled substance?
Betamethasone Dipropionate USP, 0.05% is not classified as a controlled substance by the DEA.
What is the generic name for Betamethasone Dipropionate USP, 0.05%?
The generic name for Betamethasone Dipropionate USP, 0.05% is Betamethasone Dipropionate USP, 0.05%. There are no other listed brand versions of Betamethasone Dipropionate USP, 0.05%.
What is the NDC code for Betamethasone Dipropionate USP, 0.05% .5 mg/g?
The NDC (National Drug Code) for Betamethasone Dipropionate USP, 0.05% .5 mg/g is 52817-824, listed by TruPharma LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)